Music Therapy's Impact on University Students' Social and Mental Health
Launched by THE UNIVERSITY OF HONG KONG · Jun 9, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how music therapy might help university students who are feeling stressed, anxious, or depressed. The study aims to see if music therapy can improve both mental health and social skills by comparing two different types of music activities: one where participants create their own songs with a therapist, and another where they listen to music and have group discussions without a therapy focus.
To join this study, participants need to be adults aged 18 to 40 who don’t have a diagnosed mental illness but are experiencing moderate levels of stress, anxiety, or depression related to academic challenges or social life at university. They also need to be able to speak and read Mandarin, Cantonese, or English. If eligible, participants will be randomly assigned to attend four individual sessions of either songwriting therapy or music listening with discussion. The study is currently recruiting women who meet these criteria. This is a unique opportunity to see how music can support mental well-being and social connection during a stressful time like university life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • (1) adults who aged between 18-40
- • (2) without any mental diagnosis
- • (3) able to speak and read Mandarin, Cantonese, or English
- • (4) moderate stress or problems in academic activities, problems in interpersonal relationships, or adaptability to college life.
- • (5) participants DASS-21 score \>= "Moderate" severity on each subscale (Depression \>= 14; Anxiety \>= 10; Stress \>= 19).
- Exclusion Criteria:
- • (1) has more than 10 consecutive years professional music training
- • (2) with chronic illness and taking medication
- • (3) with prior history of brain trauma or brain surgery
- • (4) wearing metal piercings or implants.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Wanru Zhao
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported